Skip to results
Modify your search
NARROW
1-14 of 14
Authors: Jian Teng
Journal Article
EXTH-60. ONCR-GBM, A NOVEL ARMED ONCOLYTIC HSV-1 VECTOR ENGINEERED FOR EFFICACY AND SAFETY IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii223, https://doi.org/10.1093/neuonc/noac209.858
Published: 14 November 2022
Journal Article
Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype Free
Neuro-Oncology, Volume 22, Issue 12, December 2020, Page 1894, https://doi.org/10.1093/neuonc/noaa166
Published: 28 October 2020
Journal Article
The natural compound obtusaquinone targets pediatric high-grade gliomas through ROS-mediated ER stress Open Access
Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdaa106, https://doi.org/10.1093/noajnl/vdaa106
Published: 27 August 2020
Journal Article
THER-03. REPURPOSING MEFLOQUINE AND ANALOGUES FOR DIPG THERAPY Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii114, https://doi.org/10.1093/neuonc/noz036.210
Published: 23 April 2019
Journal Article
THER-04. OLFACTORY ENSHEATHING CELLS TRAVEL THEIR NATURE ROUTE FROM NASAL CAVITY TO CNS AND DELIVER THERAPEUTIC TRANSGENES TO HIGH-GRADE PEDIATRIC GLIOMAS Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Pages ii114–ii115, https://doi.org/10.1093/neuonc/noz036.211
Published: 23 April 2019
Journal Article
Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy Free
JNCI: Journal of the National Cancer Institute, Volume 111, Issue 3, March 2019, Pages 283–291, https://doi.org/10.1093/jnci/djy138
Published: 25 September 2018
Journal Article
Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype Free
Neuro-Oncology, Volume 20, Issue 5, May 2018, Pages 642–654, https://doi.org/10.1093/neuonc/nox198
Published: 01 November 2017
Journal Article
Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models Free
Neuro-Oncology, Volume 19, Issue 6, 1 June 2017, Pages 820–832, https://doi.org/10.1093/neuonc/now253
Published: 06 January 2017
Journal Article
STEM-18CULTURE CONDITION-INDUCED MESENCHYMAL TRANSITION IN PATIENT-DERIVED GLIOBLASTOMA STEM CELLS Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v211–v212, https://doi.org/10.1093/neuonc/nov234.18
Published: 09 November 2015
Journal Article
ATPS-84HYDROXYUREA SENSITIZES PATIENT-DERIVED GLIOBLASTOMA TUMORS TO TEMOZOLOMIDE IRRESPECTIVE OF MGMT STATUS Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v37, https://doi.org/10.1093/neuonc/nov204.84
Published: 09 November 2015
Journal Article
Systemic Anticancer Neural Stem Cells in Combination with a Cardiac Glycoside for Glioblastoma Therapy Get access
in
Stem Cells
Stem Cells, Volume 32, Issue 8, August 2014, Pages 2021–2032, https://doi.org/10.1002/stem.1727
Published: 15 July 2014
Journal Article
The G Protein-Coupled Receptor GPR30 Inhibits Human Urothelial Cell Proliferation Get access
Endocrinology, Volume 149, Issue 8, 1 August 2008, Pages 4024–4034, https://doi.org/10.1210/en.2007-1669
Published: 01 August 2008
Journal Article
DNA–RNA chimeric hammerhead ribozyme to transforming growth factor-β1 mRNA inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats Get access
Cardiovascular Research, Volume 48, Issue 1, October 2000, Pages 138–147, https://doi.org/10.1016/S0008-6363(00)00157-7
Published: 01 October 2000
Journal Article
Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR Get access
American Journal of Hypertension, Volume 13, Issue 10, October 2000, Pages 1117–1124, https://doi.org/10.1016/S0895-7061(00)00298-3
Published: 01 October 2000
